Approved Study Database

Ref. No. Scientific Title Principal investigator
2022.049 A prospective assessment of the perioperative parameter and treatment outcomes of surgical treatment for benign prostate hyperplasia in Hong Kong Prof. NG Chi Fai
吳志輝
2023.509 To investigate the effect of multidisciplinary care approach on cardiovascular risk modification in prostate cancer patients receiving androgen deprivation therapy Prof. NG Chi Fai
Chi Fai NG
2022.051 A territory-wide retrospective study comparing the effects of different types of androgen deprivation therapy on cardiovascular disease of prostate cancer patients Prof. NG Chi Fai
吳志輝
2020.611 To identify potential new urine marker panel for cancer screening Prof. NG Chi Fai
吳志輝
2022.645 To linguistically and psychometrically validate the Hong Kong Chinese version of the BPH 3-item questionnaire Prof. NG Chi Fai
2021.492 A survey to investigate possible factors that will affect the choice of androgen deprivation therapy in prostate cancer patients Prof. NG Chi Fai
吳志輝
2021.684 A prospective assessment of the perioperative parameter and treatment outcomes of urinary calculi – international registry Prof. NG Chi Fai
吳志輝
2021.484 Randomized, Open-label, Phase 3 Study of Acapatamab vs Standard of Care in Metastatic Castration-resistant Prostate Cancer (CAPTIVATE) Prof. NG Chi Fai
吳志輝
2021.687 Surgical PRODUCT SURVEILLANCE REGISTRY (PSR) PLATFORM BASE & Medtronic Hugo™ RAS System General Surveillance in Hong Kong Product Surveillance Registry (PSR) Platform Analysis Plan Prof. NG Chi Fai
吳志輝
2023.084 Clinical Characteristics, Anticholinergic Burden, Treatment Patterns, and Drug Persistence in Patients with Overactive Bladder in Hong Kong: A Real-World Observational Study Prof. NG Chi Fai
吳志輝
2022.394 Elucidating the functional role of exosomal protein LRG1 and its clinical implication in castration-resistant prostate cancer Prof. NG Chi Fai
吳志輝
2021.675 Development of luminescent nanobiosensor for bladder cancer miRNA detection Prof. NG Chi Fai
吳志輝
2023.085 Association between nephrolithiasis and future cardiovascular events: a population-based analysis of patients utilizing public health systems in Hong Kong Prof. NG Chi Fai
吳志輝
2022.093 Exploring multiomics biomarkers for urolithiasis Prof. NG Chi Fai
吳志輝
2022.082 DAROL: Darolutamide Observational Study in non-metastatic castration-resistant prostate cancer patients Prof. NG Chi Fai
吳志輝
2022.301 A study to evaluate patient and physician benefit/ risk preferences for treatment of metastatic prostate cancer (mPC) in Hong Kong: a discrete choice experiment Prof NG Chi Fai
吳志輝
2021.506 To investigate the effect of High-Intensity Focused Electromagnetic (HIFEM) Technology in the treatment of stress urinary incontinence compared with standard of care in Chinese men who had undergone robotic radical prostatectomy Prof. NG Chi Fai
2022.158 The prevalence of Iron deficiency in Advanced Prostate Cancer Patients with Anaemia and the Impact on Patients Prof. NG Chi Fai
吳志輝
2023.180 Retrospective, Non-interventional Study Assessing the Real-Life Use of The Long-Acting Gonadotropin-releasing Hormone Agonist as A Treatment for Locally Advanced or Metastatic Prostate Cancer in Hong Kong. Prof. NG Chi Fai
吳志輝
2020.603 To investigate the role of gut microbiome in androgen deprivation therapy related metabolic changes in prostate cancer patients Prof. NG Chi Fai
吳志輝
2022.576 A retrospective study of the urinary stone composition and its epidemiological and clinical association in Hong Kong Prof. NG Chi Fai
吳志輝
2021.650 Surgery by the Medtronic Hugo™ Robotic System: A Prospective Single Centre Study Prof. NG Chi Fai
吳志輝
2022.244 The use of temporarily implanted nitinol device (iTind) system in Chinese male patients with lower urinary tract symptom secondary to benign prostate enlargement Prof. NG Chi Fai
吳志輝
2022.046 To understand the role of spermine on prostate cancer and its potential therapeutic application Prof. NG Chi Fai
吳志輝
2022.560 To study the effect of baseline testosterone level on prognosis in Asian patients with prostate cancer Prof. NG Chi Fai
吳志輝
2022.182 A Phase 2 Open-label Extension Study for Subjects with Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study Prof. NG Chi Fai
吳志輝
2018.276 A prospective randomized study to investigate the effect of extracorporeal shockwave lithotripsy on blood pressure control in patients with hypertension – a pilot study Prof. NG Chi Fai
吳志輝
2019.491 Patient Preference of Apalutamide versus Enzalutamide in Patients with Recurrent or Metastatic Hormone-Sensitive Prostate Cancer: An Open-label, Randomized, Cross-Over Trial. (version 1.0) Prof. NG Chi Fai
吳志輝
2018.280 A cross sectional study to assess the effect of androgen deprivation therapy on Gut and Urinary Microbiota in patients with prostate cancer Prof. NG Chi Fai
吳志輝
2019.166 A Phase 3 Randomized Open Label Study to Compare NKTR-214 Combined with Nivolumab to the Investigator's Choice of Sunitinib or Cabozantinib in Patients with Previously Untreated Advanced Renal Cell Carcinoma Prof. NG Chi Fai
吳志輝
2020.454 A Phase 4, randomized, open-label, multicenter efficacy and safety study of standard dose of radium-223 dichloride vs. standard doses of androgen receptor pathway inhibitor (ARPI) in patients with bone dominant metastatic castration resistant prostate cancer (mCRPC) progressing on/after one line of ARPI Prof. NG Chi Fai
吳志輝
2020.050 To evaluate the performance of a urine spermine measuring device in predicting prostate biopsy result Prof. NG Chi Fai
吳志輝
2019.534 To investigate the effect of central arterial stiffness on the progression of male bladder dysfunction, nocturia and lower urinary tract symptoms Prof. NG Chi Fai
吳志輝
2018.541 SIMCAP (Surgery in Metastatic Carcinoma of Prostate): Phase 2.5 multi-institution randomized prospective clinical trial evaluating the impact of cytoreductive radical prostatectomy combined with best systemic therapy on oncologic and quality of life outcomes in men with newly diagnosed metastatic prostate cancer Prof. NG Chi Fai
吳志輝
2020.058 Characterising and Fingerprinting Biomarkers of Urolithiasis: A Case Control Study Prof. NG Chi Fai
吳志輝
2019.662 The use of REZUM system in Chinese male patients with lower urinary tract symptom secondary to benign prostate enlargement Prof. NG Chi Fai
吳志輝
2019.211 To establish a reproducible organoid culture model with human kidney cancer Prof. NG Chi Fai
吳志輝
2018.323 Can transperineal prostate biopsy replace transrectal prostate biopsy? Hong Kong experience of the first 100 cases of transperineal prostate biopsy Prof. NG Chi Fai
吳志輝
2019.017 To investigate the possible underlying causes for patient with nocturia in Hong Kong patients Prof. NG Chi Fai
吳志輝
2018.376 To identify potential new urine markers for the screening of prostate cancer Prof. NG Chi Fai
吳志輝
2019.400 A retrospective review of the association of baseline characteristics of male patients presented with lower urinary tract and long term clinical outcomes Prof. NG Chi Fai
吳志輝
2020.185 To compare Spermine Risk Score and Prostate Health Index in diagnosing prostate cancer in Chinese patients Prof. NG Chi Fai
吳志輝
2019.378 To identify potential new genetic marker for diagnosis of cystinuria. Prof. NG Chi Fai
吳志輝
2018.063 To investigate the diagnostic accuracy of exosomal microRNA in predicting the aggressiveness of prostate cancer in Chinese patients Prof. NG Chi Fai
吳志輝
2010.474 Short stay transurethral prostate surgery: A prospective randomized controlled trial comparing efficacy of bipolar transurethral resection/vaporization of prostate with monopolar transurethral resection Prof Ng Chi Fai
2014.214 A longitudinal study on the outcome of male voiding dysfunction in Hong Kong Chinese Male Prof. NG Chi Fai
2013.536 A Randomized, Double-Blind, Parallel-Group, Placebo- and Active- Controlled, Multi-center Study to Evaluate the Efficacy, Safety and Tolerability of Combinations of Solifenacin Succinate and Mirabegron Compared to Solifenacin Succinate and Mirabegron Monotherapy in the Treatment of Overactive Bladder Prof. NG Chi Fai
2010.494 A prospective study to investigate the effect of different treatment protocols on renal injury during extracorporeal shockwave lithotripsy Prof. Ng Chi Fai
2012.105 ADJUVANT AXITINIB TREATMENT OF RENAL CANCER: A RANDOMIZED DOUBLE-BLIND PHASE 3 STUDY OF ADJUVANT AXITINIB VS. PLACEBO IN SUBJECTS AT HIGH RISK OF RECURRENT RCC Prof. NG Chi Fai
2009.620 Strategies To Prevent Renal Trauma Prof. Ng Chi Fai

Page 189 of 289.